|
|
 | | | |
- close
- close
- close
- close
Suggest other news sources for this topic
WIKI ANALYSIS
NutraCea, Inc. (OTCBB: NTRZ) is a health science company that has proprietary intellectual property that allows it to process and convert rice bran into a highly nutritious ingredient that has applications in various food products and as key components of patented and proprietary formulations that have applications for treatment modalities in nutritional supplementation. It is also used as a stand-alone products that can be sold through non-related entities with distribution into the market place, both domestically and internationally. These products include food supplements and medical foods, or “nutraceuticals,” which provide health benefits for humans and animals based on stabilized rice bran and stabilized rice bran derivatives. The company believes that stabilized rice bran products can deliver beneficial physiological effects. Management has conducted and are continuing to pursue ongoing clinical trials and third party analyses in order to further support the uses for and effectiveness of our products.[1]
The company revealed in April 2009 that it would write down the goodwill on its RiceX company by $32 million, contributing to the roughly $65 million dollar loss it posted in 2008.[2]
In June 2010 the company was in bankruptcy, and the company and a committee of its unsecured creditors revealed a plan for reorganization along with a disclosure, which as of August 2010 had not yet been approved by the bankruptcy court and put up for a vote. The plan proposes that the company sell its Dillon and Phoenix facilities to pay off its debts, and under the plan the equity interests are considered unimpaired.[3]
References
- ↑ Form 10-K 3/17/08
- ↑ See the 8-K filed April 23, 2009: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=6555665.
- ↑ See the 8-K filed June 29, 2010: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=7333613
| |||||||
